What I found when I looked · August 2026

I did the reading. Every number links to its source.

Five minutes to read, or click any figure and go as deep as you like. Where a number is my own inference rather than someone's published research, I say so.

← Back to the brief · What I've been learning → · The science room →

01 · The market

A $9–10B prestige pond. We'd only need a puddle.

$36B

US prestige beauty in 2025, up 4% — and skincare led all prestige categories in units. Circana via WWD, Jan 2026

$9–10B

US prestige skincare a year. This one is my own inference, doubled from Circana's first-half 2025 figure of $4.6B. Circana, Aug 2025

$1.5–2.5B

The part we'd actually play in: prestige serums and moisturizers bought online. Also my estimate — serums alone are a ~$1.5B US category growing 6.6% a year. Grand View Research

$150–600K

A credible first year for an indie brand without a celebrity — roughly 2,500 to 10,000 orders. The best ones reach $1M. Beauty Independent

02 · The lane

Three currents that are real. One I want to test before we spend.

+22%

Annual growth in "skin barrier repair" searches — and just about every major brand launched a barrier product in 2023. Validated, and crowded. Spate via BeautyMatter, Dec 2024

75%

Of US households buy three or fewer skincare products. Our whole company is two steps. Global Cosmetic Industry

#1

Clinical skincare dominated 2025 online sales at Sephora and Ulta. Efficacy-first is where the customer already moved. Beauty Independent

TBD

Nordic beauty has real editorial momentum (Forbes, Dec 2024) but I couldn't find hard US demand data. So we measure whether "Nordic" actually lifts conversion with small tests before real money moves.

03 · The field

Barrier is owned at $16. Nordic is owned at $130. Nobody owns both at $50–70.

BYOMA

Barrier-first at $14–20; passed $500M in cumulative retail sales in under four years. Proof the demand is there — at mass price. Yellow Wood, Sept 2025

Lumene

Owns the Nordic story at masstige ($15–40); €102M in 2024 and expanding US retail. Our cloudberry collision — and our proof the story sells. Lumene Group, Mar 2025

Verso

Swedish clinical prestige — $130 serum, aging-focused. The closest thing to our square, priced above it.

Kiehl's

Ultra Facial Cream at $38–70: the premium barrier-adjacent incumbent, "one sold every 30 seconds." The moisturizer we'd have to beat on feel and proof. kiehls.com

OSEA

A clean coastal prestige indie past $100M in revenue — evidence this lane can reach nine figures. General Atlantic

The gap is real, but it's a positioning gap, not an unmet need — barrier repair already exists at $16. So our premium has to be earned three ways at once: barrier results, design, and visible proof. The shorthand I keep using: BYOMA results, Verso design, half Verso's price.

04 · The math

The numbers that would gate every dollar.

80%

Gross-margin gate — landed cost has to be about $12 a unit or less at our prices, which is what prestige investors expect. Beauty Independent

$40–100

What it costs to acquire a DTC beauty customer today, and still rising. First orders roughly break even — the business is won on the second one. Power Digital

≥30%

The repeat-purchase rate we'd need to hit; the industry runs 28–40%. I want it instrumented from the first order. Mage Loyalty

3,000

The waitlist that would matter: at benchmark 5–15% conversion that's 150–450 launch orders. I think waitlist size is the number we should judge the whole validation budget by. DTC email benchmarks

05 · Still worries me

The case against us — and what I'd do about it.

  1. Prestige skincare dollars are nearly flat and growth is unit-led — people are trading down. So we price at the ceiling once and never above it. Circana
  2. Acquisition cost is hostile at our order size. So the model has to lean on repeat purchase and channels we own, not paid ads alone.
  3. Barrier care is available at $16. So we never sell "barrier care" — we sell proof, feel, and a two-step ritual worth its price.
  4. 2025 was a shakeout year for indie beauty. So: no inventory before evidence, no debt before demand. Business of Fashion
  5. Trademark first. The SKORR question goes to counsel before a dollar of brand money moves — my own USPTO reading is a start, not an answer.

← Back to the brief · What I've been learning → · The science room →

Plain english

The shorthand, spelled out.

Half of these you use every day. The other half are mine, and I would rather define them than have you nod along.

CAC

Customer acquisition cost. What we spend on ads and marketing to get one person to buy for the first time. Ours needs to stay under about $55–60.

LTV : CAC

Lifetime value against acquisition cost. If a customer eventually spends $180 with us and cost $60 to win, that is 3:1 — the minimum most people consider healthy.

DTC

Direct to consumer. We sell from our own website rather than through a store, so we keep the margin and own the customer relationship.

Gross margin

What is left of the sale price after the cost of making and shipping the product. Prestige skincare expects 70–80%.

COGS

Cost of goods sold. The all-in landed cost of one finished unit — formula, jar, box, freight, duty. Ours has to come in around $12.

MOQ

Minimum order quantity. The smallest batch a manufacturer will run. This is the number that decides whether we launch one product or two.

SKU

Stock keeping unit — one distinct sellable product. The serum is one SKU, the cream is another.

AOV

Average order value. What a typical basket comes to. Selling the two-step ritual together pushes ours toward $100 instead of $52.

Prestige vs masstige

Prestige is department-store and Sephora pricing. Masstige is the elevated end of drugstore. We would sit in prestige; Lumene sits in masstige.

USPTO

The US Patent and Trademark Office — where the Skírr name would be registered, and where the SKORR question gets settled.